CytoAgents Revenue and Competitors

Location

$10.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CytoAgents's estimated annual revenue is currently $1M per year.(i)
  • CytoAgents's estimated revenue per employee is $77,500
  • CytoAgents's total funding is $10.2M.

Employee Data

  • CytoAgents has 13 Employees.(i)
  • CytoAgents grew their employee count by -13% last year.

CytoAgents's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is CytoAgents?

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.

keywords:N/A

$10.2M

Total Funding

13

Number of Employees

$1M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CytoAgents News

2022-04-17 - Innovation Works investment in 2021 - Pittsburgh Business ...

cytoagents.com, $100,000, 5, $100,000, Clinical stage biotechnology company focused on the development of innovative pharmaceutical products...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M1363%N/A
#2
$3.5M130%N/A
#3
$1M13N/AN/A
#4
$1.7M130%N/A
#5
$2.6M13-7%N/A